Eitan Medical announced today that as of 16 November 2020 it has rebranded, consolidating its product lines under the new Eitan Medical brand. Eitan Medical is a global leader in advanced infusion therapy solutions across the care continuum.
Eitan Group rebrands as Eitan Medical
Eitan Medical’s product lines include the Sapphire infusion family, used across the care continuum; Sorrel’s wearable drug delivery platform, the patient-centric on-body injector for delivery of biologic treatments; and Avoset, designed specifically for home care with dedicated connected infusion systems.
CEO Igal Shany said: “Rebranding as Eitan Medical marks a major milestone and a unique opportunity for our new name to become synonymous with our advanced, connected infusion therapy solutions. Our new brand represents our evolving position – committed to delivering infusion solutions that go beyond, providing maximum flexibility for patients and reliability for clinicians across the care continuum, from the hospital to the home.”
Eitan Medical maintains local offices in the United States, France and the UK, whereby existing customers of the Sapphire product line can receive direct support and supply of infusion pumps and accessories. In addition, Eitan Medical continues to expand and successfully partner with leading pharmaceutical companies for its Sorrel wearable drug delivery platform.